Insider Trading April 24, 2026 04:43 PM

Nuveen Floating Rate Income Fund Portfolio Manager Executes Significant Stock Purchase

Scott C. Caraher increases direct holdings in JFR through consecutive transactions totaling over $102,000.

By Sofia Navarro JFR
Nuveen Floating Rate Income Fund Portfolio Manager Executes Significant Stock Purchase
JFR

Recent regulatory filings reveal that Scott C. Caraher, a portfolio manager for the Nuveen Floating Rate Income Fund (NYSE:JFR), has increased his personal stake in the fund through a series of direct stock purchases. The transactions, which occurred over two days at the conclusion of March 2026, represent a total investment of $102,569 in common stock.According to a Form 4 filing submitted to the Securities and Exchange Commission, the acquisition was split into two distinct tranches. On March 30, 2026, Mr. Caraher purchased 7,000 shares at a price of $7.2401 per share. He followed this on March 31, 2026, with another purchase of 7,000 shares, priced at $7.4127 per share.Following these recent moves, Mr. Caraher's direct ownership in the Nuveen Floating Rate Income Fund common stock stands at 59,440 shares. The timing of these purchases is notable as the fund has recently been trading at $7.46, which is near its reported 52-week low of $7.16.

Key Points

  • Portfolio manager Scott C. Caraher increased his direct ownership of JFR by $102,569 through two consecutive daily purchases.
  • The fund currently offers a 12.53% dividend yield and has a 23-year history of continuous dividend payments.
  • The recent transactions occurred while the stock was trading near its 52-week low of $7.16.

Insider Transaction Overview

Scott C. Caraher, acting in his capacity as a portfolio manager for the Nuveen Floating Rate Income Fund (NYSE:JFR), has completed a series of direct acquisitions of the fund's common stock. The total value of these transactions amounts to $102,569, executed during the final two days of March 2026.


Detailed Transaction Breakdown

The purchase activity was conducted in two separate stages:

  • March 30, 2026: An acquisition of 7,000 shares at $7.2401 per share.
  • March 31, 2026: An additional acquisition of 7,000 shares at $7.4127 per share.

These transactions bring Mr. Caraher's total direct holdings in JFR to 59,440 shares. These ownership changes were officially disclosed via a Form 4 filing with the Securities and Exchange Commission.


Market Context and Fund Performance

The fund's current share price of $7.46 places it relatively close to its 52-week low of $7.16. Despite recent price fluctuations, the fund maintains a dividend yield of 12.53%. Furthermore, the Nuveen Floating Rate Income Fund has demonstrated long-term consistency in its distributions, having maintained dividend payments for 23 consecutive years.


Key Analysis Points

  • Insider Activity: The direct purchase of shares by a portfolio manager indicates a specific level of personal capital commitment to the fund's common stock.
  • Yield Profile: With a dividend yield of 12.53% and a multi-decade history of payments, the fund focuses on income generation for its shareholders.
  • Valuation Position: The recent trading levels are situated near the bottom of the fund's 52-week range, with current prices hovering around $7.46 against a low of $7.16.

Identified Risks and Uncertainties

  • Price Volatility: The fact that the stock is trading near its 52-week low suggests recent downward pressure on the fund's valuation.
  • Market Sensitivity: As a floating rate income fund, the performance and yield may be subject to broader market and interest rate environments, though specific external drivers were not detailed in the filing.

Risks

  • The fund's current share price is trading in close proximity to its 52-week low, indicating recent valuation declines.
  • While dividend history is long, the stability of future payouts depends on the ongoing performance of the floating rate income fund.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026